C12Y 599/01002
Dna topoisomerase
Official title: DNA topoisomerase (5.99.1.2)
C12Y599/01002 (Dna topoisomerase) appears on 28 US grants and 37 published applications in this corpus.
Search patents in C12Y- Granted patents
- 28
- Published applications
- 37
- Assignees
- 23
- Inventors
- 79
- Latest grant
- 24 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 2 | 2 |
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 3 |
| 2020 | 6 | 4 |
| 2021 | 4 | 5 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
| 2024 | 1 | 4 |
| 2025 | 2 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enzymes and systems for synthesizing DNA24 Jun 2025US 12,338,470 B2Iridia, Inc.
- Modified helicases18 Mar 2025US 12,252,717 B2Oxford Nanopore Technologies PLC
- Methods for reactivating genes on the inactive X chromosome27 Feb 2024US 11,912,994 B2The General Hospital Corporation
- Enzymes and systems for synthesizing DNA23 May 2023US 11,655,465 B1Iridia, Inc.
- Modified helicases13 Dec 2022US 11,525,126 B2Oxford Nanopore Technologies PLC
- Method to generate supercoiled circular dna in vitro19 Feb 2026US 2026/0049341 A1University of Maryland, Baltimore County
- Modified helicases19 Dec 2024US 2024/0417704 A1Oxford Nanopore Technologies PLC
- Anti-hiv-1 recombinant hiv-1 derived topoisomerase ii beta kinase as an immunogen for hiv vaccine24 Oct 2024US 2024/0350618 A1University of Hyderabad
- Methods for reactivating genes on the inactive x chromosome3 Oct 2024US 2024/0327835 A1The General Hospital Corporation
- Novel enzymes and systems for synthesizing dna14 Mar 2024US 2024/0084284 A1Iridia, Inc.
Most cited
By later US patents
- Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)25US 10,286,052 B2Immatics Biotechnologies GmbH · 2019
- Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)24US 10,064,924 B2Immatics Biotechnologies GmbH · 2018
- Topoisomerase-based ligation and cloning methods13US 6,653,106 B1Sloan-Kettering Institute for Cancer Research · 2003
- Thermostable DNA Topoisomerase V11US 5,427,928 A1995
- Modified helicases9US 10,808,231 B2Oxford Nanopore Technologies PLC · 2020